Verapamil Therapy

Verapamil Therapy is a pharmacological intervention within antiarrhythmic therapy that utilizes the L-type calcium channel blocker verapamil to selectively suppress abnormal cardiac conduction, particularly in supraventricular arrhythmias, by decreasing sinoatrial and atrioventricular nodal excitability.

2.3K

Publications

112.5K

Citations

8.6K

Authors

1.9K

Institutions

Publications per year

2017–2026

123

Publications

2.3K

1–5 of 2.3K

Authors

8.6K

  1. CJ
    Carl J. Pepine

    University of Florida, United States

    33 publications · 3.5K citations

    24

    h-index

  2. RM
    Rhonda M. Cooper‐DeHoff

    University of Florida, United States

    23 publications · 2.9K citations

    18

    h-index

  3. ME
    Michel Eichelbaum

    Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Germany

    17 publications · 1.3K citations

    16

    h-index

  4. SE
    Stephen E. Epstein

    National Heart Lung and Blood Institute, United States

    15 publications · 2.1K citations

    14

    h-index

  5. DR
    Douglas R. Rosing

    National Heart Lung and Blood Institute, United States

    14 publications · 2.3K citations

    14

    h-index

1–5 of 8.6K

Venues

  1. Circulation

    81 publications · 10K citations

    53

    h-index

  2. The American Journal of Cardiology

    117 publications · 7.3K citations

    50

    h-index

  3. PubMed

    Repository · 251 publications · 9.5K citations

    44

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 54 publications · 3.2K citations

    32

    h-index

  5. Journal of Cardiovascular Pharmacology

    78 publications · 2.5K citations

    29

    h-index

1–5